Concurrent ELISA measurements revealed alterations in key RA-related mediators, including pro-inflammatory cytokines (IL-6, IL-17A, TNF-α, IL-1β), the anti-inflammatory cytokine IL-10, and matrix metalloproteinases (MMP-2, MMP-3, MMP-9). This evidence concerns the gene MMP9 and rheumatoid arthritis.